PROTAC-Mediated Multi-Target Protein Degradation in Alzheimer’s Disease: Mechanistic Insights, Therapeutic Applications, and Translational Challenges

Key Points

• The aim is to explore how Protac technology can target and degrade neurotoxic proteins involved in Alzheimer’s disease.
• Analysis of the mechanisms underlying protein degradation via Protacs.
• Evaluation of therapeutic applications for Alzheimer’s treatment.
• Discussion on the translational challenges faced in clinical settings.
• Demonstrated that Protac can efficiently reduce levels of neurotoxic proteins.
• Highlighted potential benefits of multi-target approaches over traditional therapies.
• Identified significant barriers to successful clinical translation of these therapies.